Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Duel: Dual Eligibles, FEHBP, Private Employer Coverage Debated

Executive Summary

Prescription drug costs of the dual-eligible population should be borne completely by the federal government under a new Medicare drug benefit rather than by the states under Medicaid, the National Governors Association 2003 Medicaid Reform Principles say

You may also be interested in...



Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”

The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting

Medicare AWP Reform: “Get The Doctors Out Of The Pharmacy Business”

The problems with Medicare's AWP payment system for oncology products suggests that the federal government needs to "get the doctors out of the pharmacy business," Aetna CEO John Rowe declared during a March 21 Medicare Payments Advisory Commission meeting

Medicare Rx Hinges On Senate Finance Cmte.; White House Delays Details

The prospects for a Medicare drug benefit in 2003 are likely to hinge on the ability of the Senate Finance Committee to find a bipartisan consensus over the next several months

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel